Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 22, 2013 08:00 ET | Source: Vision-Sciences, Inc.

One-Year Study Demonstrates Vision-Sciences' EndoSheath Technology Protects Against Bacterial Contamination of Bronchoscopes

ORANGEBURG, N.Y., Oct. 22, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) announced today that the detailed findings of a twelve-month evaluation of its EndoSheath® technology in...
September 09, 2013 08:40 ET | Source: Vision-Sciences, Inc.

Evaluation at UK Deployed Field Hospital Demonstrates Advantages of Vision-Sciences' EndoSheath(R) Technology for Bronchoscopy

ORANGEBURG, N.Y., Sept. 9, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
August 12, 2013 16:30 ET | Source: Vision-Sciences, Inc.

Vision-Sciences Reports First Quarter 2014 Financial Results

ORANGEBURG, N.Y., Aug. 12, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) today announced financial results for the first quarter of fiscal 2014, ended June 30, 2013. Highlights...
August 01, 2013 16:30 ET | Source: Vision-Sciences, Inc.

Vision-Sciences to Discuss First Quarter of Fiscal 2014 Results on August 13 Conference Call

ORANGEBURG, N.Y., Aug. 1, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
May 13, 2013 17:01 ET | Source: Vision-Sciences, Inc.

Vision-Sciences Appoints Howard Zauberman as Interim Chief Executive Officer

ORANGEBURG, N.Y., May 13, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
April 29, 2013 17:30 ET | Source: Vision-Sciences, Inc.

Vision-Sciences Announces Revenue of $4.2 Million for Fourth Quarter and $15.3 Million for Full Year Fiscal 2013

ORANGEBURG, N.Y., April 29, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
April 23, 2013 17:18 ET | Source: Vision-Sciences, Inc.

Vision-Sciences Announces Release Date of Fourth Quarter and Full Year Fiscal 2013 Results

ORANGEBURG, N.Y., April 23, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
March 18, 2013 16:05 ET | Source: Vision-Sciences, Inc.

Vision-Sciences Announces Launch of Next-Generation Video Endoscopy System

ORANGEBURG, N.Y., March 18, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
March 12, 2013 16:38 ET | Source: Vision-Sciences, Inc.

Vision-Sciences Appoints Cheryl Pegus, MD, MPH to Board of Directors

ORANGEBURG, N.Y., March 12, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
March 06, 2013 16:15 ET | Source: Vision-Sciences, Inc.

Vision-Sciences to Present at Canaccord Genuity Musculoskeletal Conference

ORANGEBURG, N.Y., March 6, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...